LUM and muscle atrophy: Interestingly, we noted that the muscle mass was significantly lower in muscles treated with AAV6-lumican shRNA than in those treated with AAV6-scrambled (Figure 4B), although we did not note any other signs of muscle atrophy, such as internalized nuclei, loss of nuclei, and loss of morphology (data not shown).